Company Filing History:
Years Active: 2013-2024
Title: John Grange: Innovator in Cancer Therapy
Introduction
John Grange is a prominent inventor based in London, GB. He has made significant contributions to the field of cancer therapy, holding a total of 10 patents. His work focuses on developing innovative immunomodulators aimed at enhancing cancer treatment.
Latest Patents
Among his latest patents are groundbreaking inventions such as a checkpoint inhibitor and a whole cell for use in cancer therapy. This immunomodulator is designed for the treatment, reduction, inhibition, or control of neoplastic diseases in patients undergoing checkpoint inhibition therapy. The immunomodulator can be administered simultaneously, separately, or sequentially with other treatments. Another notable patent involves an immunogenic treatment of cancer, which provides an immunomodulator for controlling neoplastic diseases in patients intended for immunogenic cell death therapy. This therapy can include various methods such as microwave irradiation, targeted radiotherapy, and photodynamic therapy, among others.
Career Highlights
John Grange has established himself as a key figure in the field of cancer research. His innovative approaches have the potential to transform cancer treatment and improve patient outcomes. He is associated with Immodulon Therapeutics Limited, where he continues to develop his ideas and inventions.
Collaborations
John collaborates with notable colleagues such as Charles Akle and Kevin Bilyard, contributing to a dynamic research environment focused on advancing cancer therapies.
Conclusion
John Grange's work in cancer therapy exemplifies the impact of innovation in medicine. His patents and collaborations highlight his commitment to improving treatment options for patients facing neoplastic diseases.